|Study of FDA Approved Catheter used for the treatment of Ventricular Tachycardia |
|Francis Marchlinski, MD|
|No longer recruiting|
Why is this study being done?
|To provide additional, corroborative safety data for an already FDA approved Catheter for treatment of patients with Ventricular Tachycardia (VT) associated with coronary artery disease.|
Who is eligible to participate in this study?
- over 18 years of age
- 4 or more documented episodes of spontaneous ventricular
tachycardia (VT) or incessant VT associated with coronary
artery disease. Episodes are documented by ECG, ICD
(implantable defibrillator / pacemaker) interrogation,
and/or telemetry strips
- failed treatment with medication
- severe heart failure
- bleeding disorder: thrombocytopenia, clotting disorder
- MI (heart attack) or cardiac surgery within 2 months
- VT not associated with coronary artery disease
- unstable angina
- certain abnormalities found on echocardiogram
What is involved with this study?
|Use of an already FDA approved catheter for treatment of VT.
**echocardiogram before and after the procedure (standard practice)
**echocardiogram and follow up visit at 6 months
**Quality of life questionnaire before procedure and at 6 month visit
**annual progress check either at office visit or by phone for 3 years
How long will this study run?
|There is no set end point.|
Who can I contact for additional information on this trial?
|Marty Sweeney, RN, RN, MS
|Mary Gnap, RN, RN, CCRC